A detailed history of Cwm, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 54 shares of STIM stock, worth $38. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54
Previous 54 -0.0%
Holding current value
$38
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024

BUY
$2.68 - $4.8 $144 - $259
54 New
54 $0
Q3 2022

Oct 27, 2022

BUY
$2.35 - $4.66 $30,387 - $60,258
12,931 New
12,931 $41,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $19.2M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.